Biomarkers: new tools for the detection of vascular risk

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
Ischaemic vascular disease, Biomarkers

Current tools to predict the risk of infarction or stroke have limited sensitivity, which is why research has focused on the identification of biomarkers in the blood for early detection of this type ...

GENESIS Biomed supports the creation of BetaScreen, the first spin-off of the Pasqual Maragall Foundation

by GENESIS Biomed

3 years ago
BetaScreen, GENESIS Biomed, Barcelonaβeta Brain Research Center, biomarkers, Alzheimer

BetaScreen’s technology is based on an algorithm capable of interpreting image biomarkers from Magnetic Resonance and CT scans, which allows to identify the presence of abnormal levels of Alzheim...

Blood-based method improves the diagnosis of bovine tuberculosis

by CIC bioGUNE

3 years ago
blood-based method+, blood-based method, bovine TB, Biomarkers, tuberculosis

A piece of research conducted in the Molecular and Functional Biomarkers group at CIC biomaGUNE, led by the Ikerbasque professor Jesús Ruiz-Cabello in collaboration with NEIKER and the UCM-Complutens...

Regional Brain Loss in NMR as a biomarker of SCA3-type dominant ataxia

by Instituto de Investigación Marqués de Valdecilla

3 years ago
hereditary ataxias, neurodegenerative diseases, biomarkers

Researchers from the hereditary ataxias and paraplegias CSUR os the University Hospital Marques de Valdecilla and IDIVAL´s neurodegenerative diseases group led by Dr. Jon Infante, participate in a Eu...

New biomarkers in blood are identified for the prognosis of abdominal aortic aneurysm risk

by Hospital de la Santa Creu i Sant Pau

3 years ago
Blood levels, molecules, biomarkers, abdominal aortic aneurysm

Blood levels of various molecules related to oxidative stress may be useful biomarkers in predicting the risk of ruptured abdominal aortic aneurysm.

CIC biomaGUNE is developing image biomarkers to study new treatments for Alzheimer's disease

by CIC bioGUNE

3 years ago
Alzheimer, new treatments, biomarkers

Alzheimer's disease is the most common cause of dementia. It is one of the principal causes of death worldwide and the second most common one among the over 70s, affecting 13 million people all over t...

A New Study Identifies Biomarkers that Can Distinguish Between Bacterial and Viral Pneumonias

by ISGlobal - Instituto de Salud Global de Barcelona

4 years ago
Biomarkers, Pneumonias, antibiotic, Bacterial Pneumonia, Viral Pneumonia, diagnostic tests

These markers could provide a basis for developing rapid diagnostic tests that help identify paediatric patients that require antibiotic treatment

Seeking out predictive biomarkers for a longer-term response to immunotherapy against NSCLC

by VHIO

4 years ago
immune-based, lung cancer, biomarkers

While the rapidly emerging arsenal of immune-based therapies continues to show great promise in more effectively tackling an increasing number of tumor types including melanoma and lung cancer, these ...

Minoryx’s clinical candidate leriglitazone shows clinical benefit in a proof of concept Phase 2 study in Friedreich´s ataxia

by Minoryx Therapeutics

4 years ago
biomarkers, Neurobiology, leriglitazone, Friedreich´s ataxia

Study demonstrates leriglitazone improves relevant disease biomarkers and ataxia resulting in clinical benefit in this orphan disease

Researchers prove the usefulness of semen miRNAs as non-invasive biomarkers for prostate cancer

by Hospital Universitari de Bellvitge

5 years ago
miRNA, semen, prostate cancer, biomarkers

Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Sara Larriba, in collaboration with Dr. Francesc Vigués and Dr. Manel Castells o...

The circulating microRNA, key biomarkers for the diagnosis of patients with stable coronary heart disease

by Hospital de la Santa Creu i Sant Pau

5 years ago
microRNA, biomarkers, coronary heart disease

Having specific biomarkers that help improve decision-making and develop new therapeutic strategies in case of coronary heart disease is key, and in this line researchers from the CIBER of Cardiovascu...

Researchers from Lleida discover a new, more precise way to diagnose pleural effusions

by IRB Lleida. Institut de Recerca Biomèdica

5 years ago
pleural effusion, cancer, biomarkers, the lungs

The pleural effusion develops by the accumulation of liquid between the walls of the lungs and the thoracic layers of the body. Most people with cancer develop this condition. The discovery of high pr...